Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)

Market Cap	10.78B
Revenue (ttm)	2.65B
Net Income (ttm)	413.22M
Shares Out	n/a
EPS (ttm)	1.77
PE Ratio	26.09
Forward PE	n/a
Dividend	1.40 (2.73%)
Ex-Dividend Date	Oct 10, 2024

Volume	2,371,647
Average Volume	801,057
Open	51.72
Previous Close	51.72
Day's Range	50.65 - 52.89
52-Week Range	49.05 - 89.27
Beta	0.48
RSI	42.27
Earnings Date	Aug 15, 2025

About SHA:688366

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,156
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688366

Financial Performance

In 2024, SHA:688366's revenue was 2.68 billion, an increase of 1.70% compared to the previous year's 2.63 billion. Earnings were 420.45 million, an increase of 1.04%.